The IBN SINA Pharmaceutical Industry PLC (DSE:IBNSINA)

Market Cap	9.79B
Revenue (ttm)	11.80B
Net Income (ttm)	632.83M
Shares Out	31.24M
EPS (ttm)	20.25
PE Ratio	15.47
Forward PE	13.57
Dividend	6.30 (2.01%)
Ex-Dividend Date	Oct 28, 2024

Volume	56,341
Average Volume	61,526
Open	315.00
Previous Close	312.80
Day's Range	311.70 - 317.80
52-Week Range	241.30 - 384.80
Beta	0.22
RSI	65.91
Earnings Date	Aug 28, 2025

About United States Steel

The IBN SINA Pharmaceutical Industry PLC produces and sells pharmaceutical drugs in Bangladesh and internationally. The company provides its products in various forms, such as solid dosage forms consisting of tablets and capsules; parenteral products covering ampoules and vials; liquid dosage forms comprising syrups, solutions, suspensions, and powder for suspension (dry syrups); and sterile ophthalmic products, creams, ointments, gels, eye drops and sachet, etc. It also offers various therapeutic products, including analgesic and anti-inflamma...

• Industry: Pharmaceutical Preparations
• Founded: 1983
• Employees: 4,200
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: IBNSINA

Financial Performance

In 2024, DSE:IBNSINA's revenue was 11.37 billion, an increase of 24.61% compared to the previous year's 9.13 billion. Earnings were 670.52 million, an increase of 10.75%.